Abstract
With the increasing emphasis on providing efficient and equitable services from primary care and against a background of increasing demands on limited resources, economic theory seeks to facilitate both the direction of primary care and the decisions that are made within it.
This paper argues that the impact of health economics, particularly at the microeconomic level, has been limited. This is because health economists have failed to recognise the importance of context, and also reflects their attempts to force reality into a disciplinary matrix which is not always accessible and acceptable to end users. Argument is made for a closer relationship between health economists and those who commission and deliver primary care. It is also desirable to develop pragmatic decision-making frameworks which draw upon economic concepts and principles but reflect the realities of the environment in which they are applied.
Similar content being viewed by others
References
Choice and opportunity - primary care, the future. London: Department of Health, 1996
Arrow KJ. Government decision making and the preciousness of life. In: Tancredi L, editor. Ethics of healthcare. Washington, DC: Washington National Academy of Sciences, 1974
Williams A. Primeval health economics in Britain: a personal retrospective of the pre-HESG (Health Economists’ Study Group) period. Health Econ 1998; 7 Suppl. 1: S3–8
Legrand J, Mays N, Mulligan JA. Learning from the NHS internal market: a review of the evidence. London: Kings Fund, 1998
Light DW. Effective commissioning. London: Office of Health Economics, 1998
Godbere E, Steiner A, Robinson R. The shifting balance towards primary care: evidence and guidelines for economic evaluation. Southampton: Institute for Health Policy Studies, University of Southampton, 1997
Scott A. Primary or secondary care? What can economics contribute to evaluation at the interface [discussion paper 02/95]? Aberdeen: Health Economics Research Unit (HERU), University of Aberdeen, 1995
Coyle D. Increasing the impact of economic evaluation on health care decision making [discussion paper 108]. York: Centre for Health Economics, University of York, 1993
The Health of Nation policy assessed. London: The Department of Health, 1998
Klein R. Priorities and rationing: pragmatism or principles? BMJ 1995; 311: 761–2
Walley T, Haycox A, Barton S. Drug rationing in the UK national health service: current status and future prospects. Pharmacoeconomics 1997; 12 (3): 339–50
Hutton J. Economic evaluation of health care: a half way technology. Health Econ 1994; 3: 1–4
Freemantle N, Maynard A. Something rotten in the state of clinical and economic analysis. Health Econ 1994; 3: 63–7
Sacristan J, Bolanos E, Hernadez J, et al. Publication bias in health economic studies [letter]. Pharmacoeconomics 1997; 11 (3): 289–90
Mason J, Drummond M. The Department of Health register of cost effectiveness studies: content and quality. Health Trends 1995; 27: 50–6
Maynard A. Economic evaluation in health care reinventing the wheel? Pharmacoeconomics 1997; 11 (2): 115–8
Maynard A. Health economics: has it fulfilled its potential? In: Maynard A, Chalmers I, editors. Non random reflections on health services research. London: BMJ Publishing Group, 1997: 163
Hammond K. Clinical intuition and clinical analysis: expertise and the cognitive continuum. In: Dowie J, Elstein A, editors. Professional judgements: a reader in clinical decision making. Cambridge: Cambridge University Press, 1998
Kernick DP, Stead J, Dixon M. Time to refocus the academic effort [editorial]. BMJ 1999; 319: 206–7
Drummond M, Brandt A, Luce B, et al. Standardising methodologies for economic evaluation in health care. Practice problems and potential. Int J Technol Assess Health Care 1993; 9 (1): 26–36
Torrance GW, Blacker D, Detsky A, et al. Creating guidelines for economic evaluations in pharmaceuticals. Pharmacoeconomics 1996; 9 (6): 553–9
Revicki D, Frank L. Pharmacoeconomic evaluation in the real world: effectiveness versus efficacy studies. Pharmacoeconomics 1999; 15 (5): 423–34
Scott A, Currie N, Donaldson C. Evaluating innovation in general practice: a pragmatic framework using programme budgeting and marginal analysis. Fam Pract 1998; 15 (3): 216–22
McIntosh E, Donaldson C, Ryan M. Recent advances in the methods of cost benefit analysis in health care. Pharmacoeconomics 1999; 15 (4): 357–67
Coast J. The appropriate use of qualitative methods in health economics. Health Econ 1999; 8 (4): 345–53
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kernick, D.P. The Impact of Health Economics on Healthcare Delivery. Pharmacoeconomics 18, 311–315 (2000). https://doi.org/10.2165/00019053-200018040-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200018040-00001